April 13, 2021
Move to delay vaccine deployment in Europe comes after six blood clot cases detected among Johnson & Johnson jab recipients in US
- Johnson & Johnson Covid vaccine to be paused in US over blood clots
- US decision to pause J&J jabs is another blow to global Covid fight
- Sweden has highest new Covid cases per person in Europe
- Austria’s health minister resigns due to ‘overwork’ during pandemic
- UK coronavirus updates – live
The US Food and Drug Administration (FDA) said it expected the recommended pause of the Johnson & Johnson vaccine rollout to be in place for a short period only.
FDA acting commissioner Janet Woodcock said it expected the pause to be a matter of days, and it was aimed at providing information to healthcare providers so that they can diagnose, treat and report such blood clots.
FDA official Peter Marks said that part of the reason for the pause was to warn doctors that administering the standard treatments for clots can cause tremendous harm, or be fatal.
Norway will start to relax some of its coronavirus restrictions and allow more people to gather in private homes and at events from Friday, prime minister Erna Solberg said.
The easing of rules at national level will not affect those in areas where the infection rate is the highest, such as in the capital region, she said.